Endocannabinoid SystemBasic Science4,821 citations
Isolation and structure of a brain constituent that binds to the cannabinoid receptor
Devane WA, Hanus L, Breuer A, et al.
Science · 1992 · DOI: 10.1126/science.1470919
Citations & References
Primary sources cited across MarijuanaResearch.com. Every citation links to the original peer-reviewed publication via DOI.
Showing 15 of 15 citations
PharmacologyReview3,241 citations
Pharmacology of cannabinoid CB1 and CB2 receptors
Pertwee RG
Pharmacology & Therapeutics · 1997 · DOI: 10.1016/S0163-7258(97)82001-3
EpilepsyRandomized Controlled Trial2,847 citations
Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome
Devinsky O, Cross JH, Laux L, et al.
New England Journal of Medicine · 2017 · DOI: 10.1056/NEJMoa1611618
Systematic ReviewSystematic Review & Meta-Analysis3,124 citations
Cannabinoids for medical use: a systematic review and meta-analysis
Whiting PF, Wolff RF, Deshpande S, et al.
JAMA · 2015 · DOI: 10.1001/jama.2015.6358
PainReview892 citations
Medical marijuana for treatment of chronic pain and other medical and psychiatric problems
Hill KP
JAMA · 2015 · DOI: 10.1001/jama.2015.6199
AnxietyRandomized Controlled Trial412 citations
Anxiolytic effects of repeated cannabidiol treatment in teenagers with social anxiety disorders
Masataka N
Frontiers in Psychology · 2019 · DOI: 10.3389/fpsyg.2019.02466
SleepReview687 citations
Cannabis, cannabinoids, and sleep: a review of the literature
Babson KA, Sottile J, Morabito D
Current Psychiatry Reports · 2017 · DOI: 10.1007/s11920-017-0775-9
Mental HealthReview534 citations
Cannabis-associated psychosis: neural substrate and clinical insights
Murray RM, Englund A, Abi-Dargham A, et al.
Neuropharmacology · 2017 · DOI: 10.1016/j.neuropharm.2017.06.018
AddictionRandomized Controlled Trial612 citations
Cannabidiol for the reduction of cue-induced craving and anxiety in drug-abstinent individuals with heroin use disorder
Hurd YL, Spriggs S, Alishayev J, et al.
American Journal of Psychiatry · 2019 · DOI: 10.1176/appi.ajp.2019.18101191
Metabolic DiseaseRandomized Controlled Trial412 citations
Efficacy and safety of cannabidiol and tetrahydrocannabivarin on glycemic and lipid parameters in patients with type 2 diabetes
Jadoon KA, Ratcliffe SH, Barrett DA, et al.
Diabetes Care · 2016 · DOI: 10.2337/dc16-0650
CognitionObservational Study1,243 citations
Cognitive functioning of long-term heavy cannabis users seeking treatment
Solowij N, Stephens RS, Roffman RA, et al.
JAMA · 2002 · DOI: 10.1001/jama.287.9.1123
NeuroprotectionPreclinical Study287 citations
Δ9-Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity
Nadal X, Del Río C, Casano S, et al.
British Journal of Pharmacology · 2017 · DOI: 10.1111/bph.13771
AntiemeticPreclinical Study312 citations
Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation
Bolognini D, Rock EM, Cluny NL, et al.
British Journal of Pharmacology · 2013 · DOI: 10.1111/bph.12043
NeurogenesisPreclinical Study187 citations
The effect of cannabichromene on adult neural stem/progenitor cells
Shinjyo N, Di Marzo V
Neurochemistry International · 2013 · DOI: 10.1016/j.neuint.2013.04.012
Endocannabinoid SystemReview3,241 citations
The endocannabinoid system and its therapeutic exploitation
Di Marzo V, Bifulco M, De Petrocellis L
Nature Reviews Drug Discovery · 2004 · DOI: 10.1038/nrd1495
Note: This page lists key citations used across MarijuanaResearch.com. Individual study pages in our Research Library contain additional references. All DOI links point to the original peer-reviewed publications. We do not cite secondary sources when primary data is available.